Compugen Ltd
NASDAQ:CGEN
Compugen Ltd
NASDAQ:CGEN
Price:
1.9 USD
-0.52%
Updated:
Apr 26, 2024
Compugen Ltd
Capital Expenditures
|
Compugen Ltd
Capital Expenditures Peer Comparison
Comparables:
Q
QNRX
B
BOLT
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Compugen Ltd
NASDAQ:CGEN
|
Capital Expenditures
-$290k
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
1%
|
|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
Capital Expenditures
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
Capital Expenditures
-₪1.4m
|
CAGR 3-Years
12%
|
CAGR 5-Years
-92%
|
CAGR 10-Years
-22%
|
See Also
What is Compugen Ltd's Capital Expenditures?
Capital Expenditures
-290k
USD
-290k
USD
Based on the financial report for Dec 31, 2023, Compugen Ltd's Capital Expenditures amounts to -290k USD.
What is Compugen Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
1%
1%
Over the last year, the Capital Expenditures growth was 41%. The average annual Capital Expenditures growth rates for Compugen Ltd have been -22% over the past three years , -13% over the past five years , and 1% over the past ten years .
You don't have any saved screeners yet
